BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28126904)

  • 1. Biochemical and Cellular Analysis Reveals Ligand Binding Specificities, a Molecular Basis for Ligand Recognition, and Membrane Association-dependent Activities of Cripto-1 and Cryptic.
    Aykul S; Parenti A; Chu KY; Reske J; Floer M; Ralston A; Martinez-Hackert E
    J Biol Chem; 2017 Mar; 292(10):4138-4151. PubMed ID: 28126904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling.
    Gray PC; Shani G; Aung K; Kelber J; Vale W
    Mol Cell Biol; 2006 Dec; 26(24):9268-78. PubMed ID: 17030617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-type specific regulation of myostatin signaling.
    Kemaladewi DU; de Gorter DJ; Aartsma-Rus A; van Ommen GJ; ten Dijke P; 't Hoen PA; Hoogaars WM
    FASEB J; 2012 Apr; 26(4):1462-72. PubMed ID: 22202673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway.
    Yan YT; Liu JJ; Luo Y; E C; Haltiwanger RS; Abate-Shen C; Shen MM
    Mol Cell Biol; 2002 Jul; 22(13):4439-49. PubMed ID: 12052855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
    Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
    J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms.
    Yeo C; Whitman M
    Mol Cell; 2001 May; 7(5):949-57. PubMed ID: 11389842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis.
    Gray PC; Vale W
    FEBS Lett; 2012 Jul; 586(14):1836-45. PubMed ID: 22306319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cripto forms a complex with activin and type II activin receptors and can block activin signaling.
    Gray PC; Harrison CA; Vale W
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5193-8. PubMed ID: 12682303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.
    Parisi S; D'Andrea D; Lago CT; Adamson ED; Persico MG; Minchiotti G
    J Cell Biol; 2003 Oct; 163(2):303-14. PubMed ID: 14581455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.
    Klauzinska M; Castro NP; Rangel MC; Spike BT; Gray PC; Bertolette D; Cuttitta F; Salomon D
    Semin Cancer Biol; 2014 Dec; 29():51-8. PubMed ID: 25153355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto.
    Harms PW; Chang C
    Genes Dev; 2003 Nov; 17(21):2624-9. PubMed ID: 14563676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cripto favors chondrocyte hypertrophy via TGF-β SMAD1/5 signaling during development of osteoarthritis.
    Garcia de Vinuesa A; Sanchez-Duffhues G; Blaney-Davidson E; van Caam A; Lodder K; Ramos Y; Kloppenburg M; Meulenbelt I; van der Kraan P; Goumans MJ; Ten Dijke P
    J Pathol; 2021 Nov; 255(3):330-342. PubMed ID: 34357595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal.
    Kelber JA; Shani G; Booker EC; Vale WW; Gray PC
    J Biol Chem; 2008 Feb; 283(8):4490-500. PubMed ID: 18089557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The threonine that carries fucose, but not fucose, is required for Cripto to facilitate Nodal signaling.
    Shi S; Ge C; Luo Y; Hou X; Haltiwanger RS; Stanley P
    J Biol Chem; 2007 Jul; 282(28):20133-41. PubMed ID: 17504756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional redundancy of EGF-CFC genes in epiblast and extraembryonic patterning during early mouse embryogenesis.
    Chu J; Shen MM
    Dev Biol; 2010 Jun; 342(1):63-73. PubMed ID: 20346354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CRIPTO/FRL-1/CRYPTIC (CFC) domain of human Cripto. Functional and structural insights through disulfide structure analysis.
    Foley SF; van Vlijmen HW; Boynton RE; Adkins HB; Cheung AE; Singh J; Sanicola M; Young CN; Wen D
    Eur J Biochem; 2003 Sep; 270(17):3610-8. PubMed ID: 12919325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development.
    Reissmann E; Jörnvall H; Blokzijl A; Andersson O; Chang C; Minchiotti G; Persico MG; Ibáñez CF; Brivanlou AH
    Genes Dev; 2001 Aug; 15(15):2010-22. PubMed ID: 11485994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth.
    Shani G; Fischer WH; Justice NJ; Kelber JA; Vale W; Gray PC
    Mol Cell Biol; 2008 Jan; 28(2):666-77. PubMed ID: 17991893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.